(Q37597811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Alexandre Chan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Eng Hooi Tan

series ordinal

1

1 reference

21 August 2017

Alexandre Chan

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

15 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1658-1666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19755624%20AND%20SRC:MED&resulttype=core&format=json

Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.

7 February 2020

cites work

1 reference

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 January 2018

1 reference

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

21 January 2018

1 reference

Evidence-based medicine. A new approach to teaching the practice of medicine

21 January 2018

1 reference

Evidence based medicine: what it is and what it isn't

21 January 2018

1 reference

A case report and discussion of cetuximab-induced folliculitis.

21 January 2018

1 reference

Efficacy and skin toxicity management with cetuximab in metastatic colorectal cancer: outcomes from an oncologic/dermatologic cooperation

21 January 2018

1 reference

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

21 January 2018

1 reference

Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy

21 January 2018

1 reference

Cetuximab-induced acneiform eruption and the response to isotretinoin

21 January 2018

1 reference

EGFR-targeted therapy and related skin toxicity

21 January 2018

1 reference

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).

21 January 2018

1 reference

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption

21 January 2018

1 reference

Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab.

21 January 2018

1 reference

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management

21 January 2018

1 reference

Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors

21 January 2018

1 reference